Concepedia

Ian Naya

IN

33

Publications

1.8K

Citations

22

H-Index

1991

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

AstraZeneca (Sweden)

University of Pennsylvania

AstraZeneca (United Kingdom)

Research Triangle Park Foundation

Ian Naya is an author at GlaxoSmithKline (United States) specializing in medicine, asthma, and allergy.

ORCID

Top concepts

Publications per year

1991–2021

33

Publications

33

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations

Piotr Kuna, Matthew Peters, A I Manjra et al. · International Journal of Clinical Practice · 2007 · 272 citations · Full text

Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids

JC Virchow, Antje Prasse, Ian Naya et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 217 citations

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

François Maltais, Leif Bjermer, Edward Kerwin et al. · Respiratory Research · 2019 · 115 citations · Full text

Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study

Gregory Feldman, Ana R. Sousa, David A. Lipson et al. · Advances in Therapy · 2017 · 110 citations · Full text

Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production.

Dana Henderson, Ian Naya, R V Bundick et al. · PubMed · 1991 · 85 citations · Full text

, , +17

Rows per page

1–5 of 33